Abstract
The drug–drug co-crystal of hydrochlorothiazide with pyrazinamide is a potential candidate for development of hydrochlorothiazide formulations for combinational therapy.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have